Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant Formula E. Sakazakii Requirement In Final Rule Unnecessary, IFC Says

This article was originally published in The Tan Sheet

Executive Summary

FDA should not create a microbiological testing requirement for E. sakazakii in infant formula, the International Formula Council states in Aug. 26 comments on the agency's proposed infant formula GMPs and quality control procedures

You may also be interested in...



Powdered Infant Formula Microbiological Testing Program Recommended

Industry and FDA should collaborate on a rigorous microbiological sampling program to test powdered infant formula for possible contaminants such as Enterobacter sakazakii bacteria, according to the agency's Food Advisory/Contaminants and Natural Toxicants Subcommittee

Infant Formula Sterility, Preparation Education Advised By FDA Panel

Increased educational efforts to help avoid the risk of serious health problems resulting from Enterobacter sakazakii bacterial contamination of powdered infant formula were recommended by an FDA advisory group at a March 19 meeting in Riverdale, Md

Codex Review Of Infant Formula Pathogen Contamination Sought By U.S.

The U.S. is requesting that the Codex Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) address concerns related to the presence of pathogens in infant formula

Topics

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel